Medical Sensors Design Conference 2018 has ended
avatar for David O'Reilly

David O'Reilly

Proteus Digital Health
Chief Platform Officer
David O’Reilly is Chief Platform Officer of Proteus Digital Health and leads the company’s sensor technology, operations and manufacturing, corporate development and corporate strategy groups. He was formerly Chief Product Officer of Proteus where he built and led the company's software, user experience and design, data sciences and product management groups. Prior to joining Proteus, David was President of Catalyst Biosciences, a company developing novel therapeutic protein products, and Chief Business Officer and member of the founding management team at Iconix Biosciences (acquired by Entelos), a genomic biomarker company. David joined Iconix from ARIAD Pharmaceuticals (NASDAQ IPO, acquired by Takeda), where he was responsible for business development and general manager of its gene therapy division. David is a graduate of Wesleyan University, where he was named the school’s Gilbert H. Clee Scholar, and the Harvard Business School, where he received an M.B.A. with Distinction.